Research Glaucoma Artificial Intelligence (AI)
Large language models (LLMs), such as ChatGPT, have skyrocketed in popularity in the last year due to their ability to utilize vast amounts of information, but could they be used to diagnose ocular disease?
Clinical Research Medical imaging Artificial Intelligence (AI)
For some, the eyes are a window into the soul. But for Jayashree Kalpathy-Cramer, PhD, professor of ophthalmology at the University of Colorado School of Medicine, they're a window into human health.
Research Patient Care Artificial Intelligence (AI)
It's not uncommon for patients to consult the internet with ocular symptoms before a physician, says Karen Christopher, MD, assistant professor in the Department of Ophthalmology at the University of Colorado School of Medicine.
Community Cornea Artificial Intelligence (AI)
Apple’s newest product addition, Vision Pro, a mixed reality headset that utilizes an eye-tracking system, is making waves in the technology community.
UCHealth
April 16, 2024
According to Naresh Mandava, MD, chair of the Department of Ophthalmology at the University of Colorado School of Medicine, the West Nile virus is a neurotrophic virus which means it primarily affects the nervous system. For patients like Sonny Hutchison with immunosuppressed systems, it can lead to temporary or — in rare instances — permanent vision problems.
Denver 7
April 05, 2024
Department of Ophthalmology resident Dallin Milner, MD, explains the perils of looking directly at the sun during a partial solar eclipse and how doing so can cause permanent eye damage.
Pueblo Chieftan
March 31, 2024
Sue Anschutz-Rodgers Eye Center specialists Niranjan Manoharan, MD, and Marc Mathias, MD, offer tips for safely viewing the eclipse and explain how retina tissue can be damaged — and will not regenerate, leading to permanent vision loss — if a person looks directly at the sun for too long.
Optometry Advisor
March 28, 2024
Optometrist Kaleb Abbott, OD, MS, FAAO, assistant professor of ophthalmology, writes that dry eye in glaucoma has created a conundrum for clinicians who attempt to manage their patients’ intraocular pressure (IOP) while simultaneously limiting ocular surface disease.
Kara Mason
